Alaska Permanent Fund Banking on Denali IPO

Posted on 11/14/2017


The Alaska Permanent Fund Corporation (APFC), through its finder Crestline Investors, invested in a number of pharmaceutical companies including Juno Therapeutics. APFC invested in several rounds in South San Francisco-based Denali Therapeutics, essentially controlling a 26.5 percent stake in the company. Denali Therapeutics submitted their IPO documents, seeking to raise US$ 100 million in capital […]